Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

July 17, 1998

Clinical evaluation of AlloMune transplantation system begins

July 15, 1998

Italian launch for Prograf announced

July 15, 1998

WF10, a unique AIDS treatment alternative evaluated in the clinic

July 13, 1998

Immunosuppressive potassium channel blockers from Merck & Co.

July 9, 1998

Multiantigen malaria vaccine evaluated in phase I/II study

July 8, 1998

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...